Biomm S.A.

São Paulo Stock Exchange:BIOM3.SA

Sector

🏥 Health Care

Industries

💊 Drugstores & Retail Pharmacies

🧬 Biotechnology

🔬 Clinical Trials

💊 Pharmaceuticals

💻 Telehealth

Location

Brazil

Market Cap

USD 169.98 M

Share Price

USD 1.30

Avg Daily Volume

41,927

Change (1 day)

1.86%

Change (1 year)

-55.24%

Change (YTD)

-24.54%

Biomm S.A. Revenue for the year ending December 31, 2024: USD 23.05 M

Biomm S.A. Revenue is USD 23.05 M for the year ending December 31, 2024, a -5.19% change year over year. Revenue is the total amount of money generated from the sales of goods or services by a company during a specific period.

Biomm S.A. Revenue for the year ending December 31, 2023 was USD 24.31 M, a 22.96% change year over year.
Biomm S.A. Revenue for the year ending December 31, 2022 was USD 19.77 M, a 3.09% change year over year.
Biomm S.A. Revenue for the year ending December 31, 2021 was USD 19.18 M, a 70.18% change year over year.
Biomm S.A. Revenue for the year ending December 31, 2020 was USD 11.27 M, a 407.07% change year over year.

Quarterly
Annual
TTM

From:

To:

Zoom:

1Y
3Y
5Y
10Y
15Y
20Y
Max

Key data

Date	Revenue	Revenue	Gross Profit	Operating Income

São Paulo Stock Exchange: BIOM3.SA

Biomm S.A.

CEO	Mr. Heraldo Carvalho Marchezini
IPO Date	Jan. 11, 2000
Location	Brazil
Headquarters	Rua dos Pinheiros, 610
Employees	130
Sector	🏥 Health Care
Industries Drugstores & Retail Pharmacies 🧬 Biotechnology 🔬 Clinical Trials 💊 Pharmaceuticals 💻 Telehealth

Description

Biomm S.A. operates as a biotechnology company in Brazil. It offers AFREZZA, a human insulin inhalation powder; CONFORT CARE, a moisturizing foot cream; GLARGILIN, a glargine insulin; and HERZUMA, a trastuzumab. Biomm S.A. was founded in 2001 and is based in São Paulo, Brazil.

Similar companies

AbbVie Inc.

USD 182.31

-2.40%

Roche Holding AG

USD 347.50

0.20%

AstraZeneca PLC

USD 140.24

0.73%

Merck & Co., Inc.

USD 79.10

0.34%

Amgen Inc.

USD 277.13

-0.71%

Pfizer Inc.

USD 24.19

-0.21%

Gilead Sciences, Inc.

USD 110.67

2.83%

Sanofi

USD 96.65

0.37%

Bristol-Myers Squibb Company

USD 46.35

-0.64%

Chugai Pharmaceutical Co., Ltd.

USD 51.91

-1.13%

GSK plc

USD 19.28

0.69%

Regeneron Pharmaceuticals, Inc.

USD 521.00

0.00%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.24

-0.32%

Takeda Pharmaceutical Company Limited

USD 30.16

-0.03%

UCB SA

USD 199.41

0.97%

Hansoh Pharmaceutical Group Company Limited

USD 3.71

-0.01%

Insmed Incorporated

USD 99.49

-2.21%

Summit Therapeutics Inc.

USD 20.60

-3.38%

Torrent Pharmaceuticals Limited

USD 39.09

3.96%

Mankind Pharma Limited

USD 27.30

1.56%

Ascendis Pharma A/S

USD 172.22

-0.42%

Lupin Limited

USD 22.64

0.60%

BioMarin Pharmaceutical Inc.

USD 55.17

1.98%

Swedish Orphan Biovitrum AB (publ)

USD 29.88

2.57%

Ipsen S.A.

USD 120.09

-0.15%

Huadong Medicine Co., Ltd

USD 5.63

0.53%

Kyowa Kirin Co., Ltd.

USD 16.88

-1.46%

Shanghai Fosun Pharmaceutical (Group) Co., Ltd.

USD 2.07

0.74%

Shenzhen Salubris Pharmaceuticals Co., Ltd.

USD 6.52

1.58%

Haisco Pharmaceutical Group Co., Ltd.

USD 5.91

0.12%

3SBio Inc.

USD 2.89

3.41%

Ionis Pharmaceuticals, Inc.

USD 39.80

0.05%

ALK-Abelló A/S

USD 29.04

0.41%

Glaukos Corporation

USD 101.42

0.36%

Yuhan Corporation

USD 75.63

1.29%

H. Lundbeck A/S

USD 5.60

0.14%

Ono Pharmaceutical Co., Ltd.

USD 10.67

0.42%

Alkermes plc

USD 28.81

-0.07%

Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd

USD 7.44

-0.33%

Gan & Lee Pharmaceuticals.

USD 7.48

0.19%

Cohance Lifesciences Limited

USD 11.04

-5.54%

ADMA Biologics, Inc.

USD 18.16

-1.30%

Laurus Labs Limited

USD 8.21

3.42%

Livzon Pharmaceutical Group Inc.

USD 3.74

1.90%

Suzhou Zelgen Biopharmaceuticals Co., Ltd.

USD 15.04

-5.17%

Ipca Laboratories Limited

USD 15.58

-0.70%

Zealand Pharma A/S

USD 56.38

2.01%

PTC Therapeutics, Inc.

USD 49.84

0.58%

ACADIA Pharmaceuticals Inc.

USD 22.12

-0.40%

Chengdu Kanghong Pharmaceutical Group Co., Ltd

USD 3.99

1.27%

StockViz Staff

June 30, 2025

Any question? Send us an email